Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 131.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 137.50
  • 52 Week Low: 100.50
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 818
  • Market Cap: £139.16m
  • RiskGrade: 54

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
24.67% above the market average24.67% above the market average24.67% above the market average24.67% above the market average24.67% above the market average
17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average
1yr Revenue Growth
55.24% below the market average55.24% below the market average55.24% below the market average55.24% below the market average55.24% below the market average
57.58% below the sector average57.58% below the sector average57.58% below the sector average57.58% below the sector average57.58% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
13.89% below the market average13.89% below the market average13.89% below the market average13.89% below the market average13.89% below the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
1yr DPS Growth
7.55% above the market average7.55% above the market average7.55% above the market average7.55% above the market average7.55% above the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
56.65% below the market average56.65% below the market average56.65% below the market average56.65% below the market average56.65% below the market average
92.31% below the sector average92.31% below the sector average92.31% below the sector average92.31% below the sector average92.31% below the sector average
Price Book Ratio
23.27% below the market average23.27% below the market average23.27% below the market average23.27% below the market average23.27% below the market average
31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
42.83% above the market average42.83% above the market average42.83% above the market average42.83% above the market average42.83% above the market average
30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average
Price Chg 3m
44.16% above the market average44.16% above the market average44.16% above the market average44.16% above the market average44.16% above the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
68.22% above the market average68.22% above the market average68.22% above the market average68.22% above the market average68.22% above the market average
58.97% above the sector average58.97% above the sector average58.97% above the sector average58.97% above the sector average58.97% above the sector average
Momentum 20
33.62% above the market average33.62% above the market average33.62% above the market average33.62% above the market average33.62% above the market average
28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
16.29% below the market average16.29% below the market average16.29% below the market average16.29% below the market average16.29% below the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average
ROCE
72.33% above the market average72.33% above the market average72.33% above the market average72.33% above the market average72.33% above the market average
47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
22.59% above the market average22.59% above the market average22.59% above the market average22.59% above the market average22.59% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Forecast EPS
41.27% below the market average41.27% below the market average41.27% below the market average41.27% below the market average41.27% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
43.73% above the market average43.73% above the market average43.73% above the market average43.73% above the market average43.73% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Operating Profit Loss
25.57% above the market average25.57% above the market average25.57% above the market average25.57% above the market average25.57% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
30.15% above the market average30.15% above the market average30.15% above the market average30.15% above the market average30.15% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
Cash
7.54% above the market average7.54% above the market average7.54% above the market average7.54% above the market average7.54% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
13.51% above the market average13.51% above the market average13.51% above the market average13.51% above the market average13.51% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Buys 1y
0.09% below the market average0.09% below the market average0.09% below the market average0.09% below the market average0.09% below the market average
24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
53.75% below the market average53.75% below the market average53.75% below the market average53.75% below the market average53.75% below the market average
52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average
Brokers Percent Neutral
34.30% above the market average34.30% above the market average34.30% above the market average34.30% above the market average34.30% above the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 131.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 137.50
52 Week Low 100.50
Volume 818
Shares Issued 106.23m
Market Cap £139.16m
RiskGrade 54

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
61.75% below the market average61.75% below the market average61.75% below the market average61.75% below the market average61.75% below the market average
82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average
Price Trend
42.83% above the market average42.83% above the market average42.83% above the market average42.83% above the market average42.83% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income
9.38% above the market average9.38% above the market average9.38% above the market average9.38% above the market average9.38% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average
Growth
32.09% below the market average32.09% below the market average32.09% below the market average32.09% below the market average32.09% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 06-Dec-2019

Time Volume / Share Price
15:08 785 @ 130.50p
14:08 15 @ 130.50p
14:07 18 @ 130.50p

Cello Health Key Personnel

CEO Mark Scott

Top of Page